Trials / Active Not Recruiting
Active Not RecruitingNCT05010590
Anabolic Therapy in Postmenopausal Osteoporosis
- Status
- Active Not Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Massachusetts General Hospital · Academic / Other
- Sex
- Female
- Age
- 45 Years
- Healthy volunteers
- Accepted
Summary
In this research study we want to learn more about the effect of two different FDA-approved medications in the treatment of osteoporosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Romosozumab | Monthly romosozumab |
| DRUG | Denosumab | Every 6 months denosumab |
Timeline
- Start date
- 2022-03-24
- Primary completion
- 2027-10-01
- Completion
- 2027-11-01
- First posted
- 2021-08-18
- Last updated
- 2026-04-15
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05010590. Inclusion in this directory is not an endorsement.